nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Ifosfamide—germ cell cancer	0.191	0.325	CbGbCtD
Moclobemide—CYP2C9—Ifosfamide—germ cell cancer	0.159	0.27	CbGbCtD
Moclobemide—CYP1A2—Etoposide—germ cell cancer	0.0844	0.143	CbGbCtD
Moclobemide—CYP2C9—Cisplatin—germ cell cancer	0.0774	0.131	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—germ cell cancer	0.0772	0.131	CbGbCtD
Moclobemide—CYP2C9—cardial valve—germ cell cancer	0.0323	0.199	CbGeAlD
Moclobemide—CYP2C19—urine—germ cell cancer	0.00897	0.0553	CbGeAlD
Moclobemide—CYP1A2—urine—germ cell cancer	0.00733	0.0452	CbGeAlD
Moclobemide—MAOB—ganglion—germ cell cancer	0.00702	0.0433	CbGeAlD
Moclobemide—CYP2C9—urine—germ cell cancer	0.00696	0.0429	CbGeAlD
Moclobemide—Procainamide—SLC22A3—germ cell cancer	0.00667	1	CrCbGaD
Moclobemide—MAOA—ganglion—germ cell cancer	0.00599	0.0369	CbGeAlD
Moclobemide—CYP2D6—urine—germ cell cancer	0.00522	0.0322	CbGeAlD
Moclobemide—Anorectal discomfort—Etoposide—germ cell cancer	0.00465	0.0192	CcSEcCtD
Moclobemide—Delusion—Ifosfamide—germ cell cancer	0.00454	0.0188	CcSEcCtD
Moclobemide—Aggression—Bleomycin—germ cell cancer	0.00428	0.0177	CcSEcCtD
Moclobemide—MAOB—trigeminal ganglion—germ cell cancer	0.00345	0.0213	CbGeAlD
Moclobemide—MAOA—neck—germ cell cancer	0.0034	0.021	CbGeAlD
Moclobemide—Dysarthria—Ifosfamide—germ cell cancer	0.0034	0.0141	CcSEcCtD
Moclobemide—MAOB—embryo—germ cell cancer	0.00333	0.0205	CbGeAlD
Moclobemide—Appetite absent—Methotrexate—germ cell cancer	0.00306	0.0126	CcSEcCtD
Moclobemide—Disorientation—Bleomycin—germ cell cancer	0.00305	0.0126	CcSEcCtD
Moclobemide—MAOB—brainstem—germ cell cancer	0.00305	0.0188	CbGeAlD
Moclobemide—MAOA—trigeminal ganglion—germ cell cancer	0.00294	0.0181	CbGeAlD
Moclobemide—Dysarthria—Cisplatin—germ cell cancer	0.00293	0.0121	CcSEcCtD
Moclobemide—Urine output increased—Ifosfamide—germ cell cancer	0.00291	0.012	CcSEcCtD
Moclobemide—MAOA—embryo—germ cell cancer	0.00284	0.0175	CbGeAlD
Moclobemide—Angina pectoris—Vinblastine—germ cell cancer	0.00272	0.0113	CcSEcCtD
Moclobemide—MAOB—telencephalon—germ cell cancer	0.00271	0.0167	CbGeAlD
Moclobemide—Polyuria—Ifosfamide—germ cell cancer	0.00266	0.011	CcSEcCtD
Moclobemide—Disorientation—Ifosfamide—germ cell cancer	0.00261	0.0108	CcSEcCtD
Moclobemide—MAOA—brainstem—germ cell cancer	0.0026	0.016	CbGeAlD
Moclobemide—MAOB—decidua—germ cell cancer	0.00257	0.0158	CbGeAlD
Moclobemide—MAOA—retina—germ cell cancer	0.00251	0.0155	CbGeAlD
Moclobemide—Osteoarthritis—Ifosfamide—germ cell cancer	0.00233	0.00965	CcSEcCtD
Moclobemide—MAOA—telencephalon—germ cell cancer	0.00231	0.0142	CbGeAlD
Moclobemide—Polyuria—Cisplatin—germ cell cancer	0.00229	0.00948	CcSEcCtD
Moclobemide—MAOB—uterus—germ cell cancer	0.00224	0.0138	CbGeAlD
Moclobemide—MAOB—pituitary gland—germ cell cancer	0.0022	0.0136	CbGeAlD
Moclobemide—MAOA—decidua—germ cell cancer	0.00219	0.0135	CbGeAlD
Moclobemide—MAOB—medulla oblongata—germ cell cancer	0.00213	0.0131	CbGeAlD
Moclobemide—Stomatitis—Bleomycin—germ cell cancer	0.00205	0.00848	CcSEcCtD
Moclobemide—MAOB—adrenal gland—germ cell cancer	0.00197	0.0121	CbGeAlD
Moclobemide—Angina pectoris—Ifosfamide—germ cell cancer	0.00197	0.00813	CcSEcCtD
Moclobemide—MAOB—midbrain—germ cell cancer	0.00194	0.012	CbGeAlD
Moclobemide—Gingivitis—Methotrexate—germ cell cancer	0.00194	0.00801	CcSEcCtD
Moclobemide—Irritability—Cisplatin—germ cell cancer	0.00192	0.00794	CcSEcCtD
Moclobemide—MAOA—uterus—germ cell cancer	0.00191	0.0118	CbGeAlD
Moclobemide—Stomatitis—Dactinomycin—germ cell cancer	0.00191	0.00791	CcSEcCtD
Moclobemide—MAOB—spinal cord—germ cell cancer	0.0019	0.0117	CbGeAlD
Moclobemide—Dysuria—Ifosfamide—germ cell cancer	0.00189	0.0078	CcSEcCtD
Moclobemide—MAOA—pituitary gland—germ cell cancer	0.00188	0.0116	CbGeAlD
Moclobemide—MAOB—female gonad—germ cell cancer	0.00184	0.0113	CbGeAlD
Moclobemide—MAOA—medulla oblongata—germ cell cancer	0.00181	0.0112	CbGeAlD
Moclobemide—Ill-defined disorder—Vinblastine—germ cell cancer	0.00181	0.00747	CcSEcCtD
Moclobemide—Malaise—Vinblastine—germ cell cancer	0.00176	0.00726	CcSEcCtD
Moclobemide—Flushing—Bleomycin—germ cell cancer	0.00175	0.00725	CcSEcCtD
Moclobemide—Stomatitis—Ifosfamide—germ cell cancer	0.00175	0.00725	CcSEcCtD
Moclobemide—Conjunctivitis—Ifosfamide—germ cell cancer	0.00175	0.00723	CcSEcCtD
Moclobemide—MAOB—endocrine gland—germ cell cancer	0.00171	0.0105	CbGeAlD
Moclobemide—MAOB—head—germ cell cancer	0.00169	0.0104	CbGeAlD
Moclobemide—Hypertension—Vinblastine—germ cell cancer	0.00168	0.00695	CcSEcCtD
Moclobemide—MAOA—adrenal gland—germ cell cancer	0.00168	0.0104	CbGeAlD
Moclobemide—MAOA—midbrain—germ cell cancer	0.00166	0.0102	CbGeAlD
Moclobemide—Bradycardia—Ifosfamide—germ cell cancer	0.00164	0.0068	CcSEcCtD
Moclobemide—Discomfort—Vinblastine—germ cell cancer	0.00164	0.00677	CcSEcCtD
Moclobemide—Flushing—Dactinomycin—germ cell cancer	0.00164	0.00676	CcSEcCtD
Moclobemide—MAOB—testis—germ cell cancer	0.00163	0.01	CbGeAlD
Moclobemide—MAOA—spinal cord—germ cell cancer	0.00162	0.00998	CbGeAlD
Moclobemide—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00161	0.00665	CcSEcCtD
Moclobemide—Dysarthria—Methotrexate—germ cell cancer	0.00161	0.00665	CcSEcCtD
Moclobemide—Hallucination—Ifosfamide—germ cell cancer	0.00161	0.00664	CcSEcCtD
Moclobemide—MAOA—female gonad—germ cell cancer	0.00157	0.00966	CbGeAlD
Moclobemide—Visual impairment—Ifosfamide—germ cell cancer	0.00156	0.00644	CcSEcCtD
Moclobemide—CYP2D6—brainstem—germ cell cancer	0.00155	0.00954	CbGeAlD
Moclobemide—Ill-defined disorder—Bleomycin—germ cell cancer	0.00153	0.00631	CcSEcCtD
Moclobemide—Stomatitis—Cisplatin—germ cell cancer	0.00151	0.00625	CcSEcCtD
Moclobemide—Conjunctivitis—Cisplatin—germ cell cancer	0.00151	0.00623	CcSEcCtD
Moclobemide—Tinnitus—Ifosfamide—germ cell cancer	0.00151	0.00623	CcSEcCtD
Moclobemide—MAOB—cerebellum—germ cell cancer	0.0015	0.00927	CbGeAlD
Moclobemide—Flushing—Ifosfamide—germ cell cancer	0.0015	0.0062	CcSEcCtD
Moclobemide—CYP2C19—endocrine gland—germ cell cancer	0.00149	0.00918	CbGeAlD
Moclobemide—Malaise—Bleomycin—germ cell cancer	0.00148	0.00613	CcSEcCtD
Moclobemide—MAOA—endocrine gland—germ cell cancer	0.00146	0.00898	CbGeAlD
Moclobemide—MAOA—head—germ cell cancer	0.00144	0.00887	CbGeAlD
Moclobemide—Paraesthesia—Vinblastine—germ cell cancer	0.00143	0.0059	CcSEcCtD
Moclobemide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00142	0.00589	CcSEcCtD
Moclobemide—Bradycardia—Cisplatin—germ cell cancer	0.00142	0.00586	CcSEcCtD
Moclobemide—Chest pain—Bleomycin—germ cell cancer	0.0014	0.00579	CcSEcCtD
Moclobemide—Myalgia—Bleomycin—germ cell cancer	0.0014	0.00579	CcSEcCtD
Moclobemide—MAOA—testis—germ cell cancer	0.00139	0.00857	CbGeAlD
Moclobemide—Stomatitis—Etoposide—germ cell cancer	0.00139	0.00573	CcSEcCtD
Moclobemide—Discomfort—Bleomycin—germ cell cancer	0.00138	0.00572	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—germ cell cancer	0.00138	0.00572	CcSEcCtD
Moclobemide—Decreased appetite—Vinblastine—germ cell cancer	0.00138	0.00571	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—germ cell cancer	0.00138	0.00569	CcSEcCtD
Moclobemide—CYP2D6—telencephalon—germ cell cancer	0.00137	0.00846	CbGeAlD
Moclobemide—Constipation—Vinblastine—germ cell cancer	0.00136	0.00562	CcSEcCtD
Moclobemide—Confusional state—Bleomycin—germ cell cancer	0.00135	0.0056	CcSEcCtD
Moclobemide—Visual impairment—Cisplatin—germ cell cancer	0.00134	0.00555	CcSEcCtD
Moclobemide—Vision blurred—Ifosfamide—germ cell cancer	0.00133	0.00548	CcSEcCtD
Moclobemide—Feeling abnormal—Vinblastine—germ cell cancer	0.00131	0.00542	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—germ cell cancer	0.00131	0.0054	CcSEcCtD
Moclobemide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.0013	0.00539	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0013	0.00537	CcSEcCtD
Moclobemide—Tinnitus—Cisplatin—germ cell cancer	0.0013	0.00537	CcSEcCtD
Moclobemide—Flushing—Cisplatin—germ cell cancer	0.00129	0.00534	CcSEcCtD
Moclobemide—Agitation—Ifosfamide—germ cell cancer	0.00129	0.00534	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—germ cell cancer	0.00129	0.00534	CcSEcCtD
Moclobemide—MAOA—cerebellum—germ cell cancer	0.00128	0.00791	CbGeAlD
Moclobemide—Malaise—Ifosfamide—germ cell cancer	0.00127	0.00524	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—germ cell cancer	0.00126	0.0052	CcSEcCtD
Moclobemide—Abdominal pain—Vinblastine—germ cell cancer	0.00126	0.0052	CcSEcCtD
Moclobemide—Hypotension—Bleomycin—germ cell cancer	0.00125	0.00519	CcSEcCtD
Moclobemide—Palpitations—Ifosfamide—germ cell cancer	0.00124	0.00514	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00122	0.00506	CcSEcCtD
Moclobemide—MAOB—brain—germ cell cancer	0.00122	0.00753	CbGeAlD
Moclobemide—CYP1A2—endocrine gland—germ cell cancer	0.00122	0.0075	CbGeAlD
Moclobemide—Hypertension—Ifosfamide—germ cell cancer	0.00121	0.00502	CcSEcCtD
Moclobemide—Paraesthesia—Bleomycin—germ cell cancer	0.00121	0.00498	CcSEcCtD
Moclobemide—Dyspnoea—Bleomycin—germ cell cancer	0.0012	0.00495	CcSEcCtD
Moclobemide—Myalgia—Ifosfamide—germ cell cancer	0.0012	0.00495	CcSEcCtD
Moclobemide—Chest pain—Ifosfamide—germ cell cancer	0.0012	0.00495	CcSEcCtD
Moclobemide—Flatulence—Cisplatin—germ cell cancer	0.00119	0.00494	CcSEcCtD
Moclobemide—Flushing—Etoposide—germ cell cancer	0.00118	0.00489	CcSEcCtD
Moclobemide—Discomfort—Ifosfamide—germ cell cancer	0.00118	0.00489	CcSEcCtD
Moclobemide—MAOB—lymph node—germ cell cancer	0.00118	0.00728	CbGeAlD
Moclobemide—Decreased appetite—Bleomycin—germ cell cancer	0.00117	0.00483	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—germ cell cancer	0.00117	0.00482	CcSEcCtD
Moclobemide—Confusional state—Ifosfamide—germ cell cancer	0.00116	0.00478	CcSEcCtD
Moclobemide—CYP2C9—endocrine gland—germ cell cancer	0.00115	0.00711	CbGeAlD
Moclobemide—Vision blurred—Cisplatin—germ cell cancer	0.00114	0.00472	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00114	0.00472	CcSEcCtD
Moclobemide—Asthenia—Vinblastine—germ cell cancer	0.00114	0.00472	CcSEcCtD
Moclobemide—Tremor—Cisplatin—germ cell cancer	0.00114	0.0047	CcSEcCtD
Moclobemide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00112	0.00465	CcSEcCtD
Moclobemide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00111	0.00459	CcSEcCtD
Moclobemide—Feeling abnormal—Bleomycin—germ cell cancer	0.00111	0.00457	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—germ cell cancer	0.0011	0.00457	CcSEcCtD
Moclobemide—Malaise—Cisplatin—germ cell cancer	0.00109	0.00452	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—germ cell cancer	0.00109	0.0045	CcSEcCtD
Moclobemide—Diarrhoea—Vinblastine—germ cell cancer	0.00109	0.0045	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—germ cell cancer	0.00109	0.0045	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—germ cell cancer	0.00108	0.00446	CcSEcCtD
Moclobemide—Hypotension—Ifosfamide—germ cell cancer	0.00107	0.00443	CcSEcCtD
Moclobemide—Urticaria—Bleomycin—germ cell cancer	0.00107	0.00441	CcSEcCtD
Moclobemide—Irritability—Methotrexate—germ cell cancer	0.00105	0.00436	CcSEcCtD
Moclobemide—Dizziness—Vinblastine—germ cell cancer	0.00105	0.00435	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00105	0.00432	CcSEcCtD
Moclobemide—MAOA—brain—germ cell cancer	0.00104	0.00643	CbGeAlD
Moclobemide—Myalgia—Cisplatin—germ cell cancer	0.00103	0.00427	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00103	0.00427	CcSEcCtD
Moclobemide—Paraesthesia—Ifosfamide—germ cell cancer	0.00103	0.00426	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—germ cell cancer	0.00103	0.00426	CcSEcCtD
Moclobemide—Anxiety—Cisplatin—germ cell cancer	0.00103	0.00425	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00102	0.00423	CcSEcCtD
Moclobemide—Dyspnoea—Ifosfamide—germ cell cancer	0.00102	0.00423	CcSEcCtD
Moclobemide—Somnolence—Ifosfamide—germ cell cancer	0.00102	0.00422	CcSEcCtD
Moclobemide—Discomfort—Cisplatin—germ cell cancer	0.00102	0.00422	CcSEcCtD
Moclobemide—Vomiting—Vinblastine—germ cell cancer	0.00101	0.00418	CcSEcCtD
Moclobemide—MAOA—lymph node—germ cell cancer	0.00101	0.00621	CbGeAlD
Moclobemide—Malaise—Etoposide—germ cell cancer	0.001	0.00414	CcSEcCtD
Moclobemide—Decreased appetite—Ifosfamide—germ cell cancer	0.000998	0.00412	CcSEcCtD
Moclobemide—Headache—Vinblastine—germ cell cancer	0.000996	0.00412	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—germ cell cancer	0.00099	0.00409	CcSEcCtD
Moclobemide—Fatigue—Ifosfamide—germ cell cancer	0.000989	0.00409	CcSEcCtD
Moclobemide—Constipation—Ifosfamide—germ cell cancer	0.000981	0.00406	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—germ cell cancer	0.000976	0.00404	CcSEcCtD
Moclobemide—Tachycardia—Cisplatin—germ cell cancer	0.000965	0.00399	CcSEcCtD
Moclobemide—Asthenia—Bleomycin—germ cell cancer	0.000963	0.00398	CcSEcCtD
Moclobemide—Hypertension—Etoposide—germ cell cancer	0.000959	0.00396	CcSEcCtD
Moclobemide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000956	0.00395	CcSEcCtD
Moclobemide—Pruritus—Bleomycin—germ cell cancer	0.00095	0.00393	CcSEcCtD
Moclobemide—Feeling abnormal—Ifosfamide—germ cell cancer	0.000946	0.00391	CcSEcCtD
Moclobemide—Chest pain—Etoposide—germ cell cancer	0.000945	0.00391	CcSEcCtD
Moclobemide—Nausea—Vinblastine—germ cell cancer	0.000944	0.0039	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000938	0.00388	CcSEcCtD
Moclobemide—Discomfort—Etoposide—germ cell cancer	0.000934	0.00386	CcSEcCtD
Moclobemide—CYP2D6—female gonad—germ cell cancer	0.000931	0.00574	CbGeAlD
Moclobemide—Hypotension—Cisplatin—germ cell cancer	0.000924	0.00382	CcSEcCtD
Moclobemide—Confusional state—Etoposide—germ cell cancer	0.000914	0.00378	CcSEcCtD
Moclobemide—Urticaria—Ifosfamide—germ cell cancer	0.000912	0.00377	CcSEcCtD
Moclobemide—Abdominal pain—Ifosfamide—germ cell cancer	0.000907	0.00375	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000901	0.00373	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—germ cell cancer	0.000898	0.00371	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—germ cell cancer	0.000893	0.00369	CcSEcCtD
Moclobemide—Paraesthesia—Cisplatin—germ cell cancer	0.000888	0.00367	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—germ cell cancer	0.000885	0.00366	CcSEcCtD
Moclobemide—Dyspnoea—Cisplatin—germ cell cancer	0.000882	0.00365	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—germ cell cancer	0.000876	0.00362	CcSEcCtD
Moclobemide—CYP2D6—endocrine gland—germ cell cancer	0.000866	0.00534	CbGeAlD
Moclobemide—Decreased appetite—Cisplatin—germ cell cancer	0.00086	0.00356	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—germ cell cancer	0.000857	0.00354	CcSEcCtD
Moclobemide—CYP2D6—head—germ cell cancer	0.000854	0.00527	CbGeAlD
Moclobemide—Vomiting—Bleomycin—germ cell cancer	0.000854	0.00353	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—germ cell cancer	0.000851	0.00352	CcSEcCtD
Moclobemide—Hypotension—Etoposide—germ cell cancer	0.000847	0.0035	CcSEcCtD
Moclobemide—Rash—Bleomycin—germ cell cancer	0.000847	0.0035	CcSEcCtD
Moclobemide—Dermatitis—Bleomycin—germ cell cancer	0.000846	0.0035	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—germ cell cancer	0.00083	0.00343	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—germ cell cancer	0.000827	0.00342	CcSEcCtD
Moclobemide—CYP2D6—testis—germ cell cancer	0.000825	0.00509	CbGeAlD
Moclobemide—Asthenia—Ifosfamide—germ cell cancer	0.000823	0.0034	CcSEcCtD
Moclobemide—Sweating—Methotrexate—germ cell cancer	0.000816	0.00337	CcSEcCtD
Moclobemide—Feeling abnormal—Cisplatin—germ cell cancer	0.000815	0.00337	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—germ cell cancer	0.000814	0.00336	CcSEcCtD
Moclobemide—Pruritus—Ifosfamide—germ cell cancer	0.000812	0.00336	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—germ cell cancer	0.000808	0.00334	CcSEcCtD
Moclobemide—Somnolence—Etoposide—germ cell cancer	0.000806	0.00333	CcSEcCtD
Moclobemide—Nausea—Bleomycin—germ cell cancer	0.000798	0.0033	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—germ cell cancer	0.000796	0.00329	CcSEcCtD
Moclobemide—Rash—Dactinomycin—germ cell cancer	0.00079	0.00326	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—germ cell cancer	0.000788	0.00326	CcSEcCtD
Moclobemide—Diarrhoea—Ifosfamide—germ cell cancer	0.000785	0.00325	CcSEcCtD
Moclobemide—Fatigue—Etoposide—germ cell cancer	0.000781	0.00323	CcSEcCtD
Moclobemide—Constipation—Etoposide—germ cell cancer	0.000775	0.0032	CcSEcCtD
Moclobemide—CYP2D6—cerebellum—germ cell cancer	0.000762	0.0047	CbGeAlD
Moclobemide—Dizziness—Ifosfamide—germ cell cancer	0.000759	0.00314	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—germ cell cancer	0.000747	0.00309	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—germ cell cancer	0.000744	0.00308	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000741	0.00306	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—germ cell cancer	0.000736	0.00304	CcSEcCtD
Moclobemide—Vomiting—Ifosfamide—germ cell cancer	0.00073	0.00302	CcSEcCtD
Moclobemide—Rash—Ifosfamide—germ cell cancer	0.000724	0.00299	CcSEcCtD
Moclobemide—Dermatitis—Ifosfamide—germ cell cancer	0.000723	0.00299	CcSEcCtD
Moclobemide—Urticaria—Etoposide—germ cell cancer	0.00072	0.00298	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—germ cell cancer	0.000716	0.00296	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—germ cell cancer	0.000712	0.00295	CcSEcCtD
Moclobemide—Asthenia—Cisplatin—germ cell cancer	0.00071	0.00293	CcSEcCtD
Moclobemide—Nausea—Ifosfamide—germ cell cancer	0.000682	0.00282	CcSEcCtD
Moclobemide—Diarrhoea—Cisplatin—germ cell cancer	0.000677	0.0028	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—germ cell cancer	0.000651	0.00269	CcSEcCtD
Moclobemide—Asthenia—Etoposide—germ cell cancer	0.00065	0.00269	CcSEcCtD
Moclobemide—Pruritus—Etoposide—germ cell cancer	0.000641	0.00265	CcSEcCtD
Moclobemide—Vomiting—Cisplatin—germ cell cancer	0.000629	0.0026	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—germ cell cancer	0.000627	0.00259	CcSEcCtD
Moclobemide—Rash—Cisplatin—germ cell cancer	0.000624	0.00258	CcSEcCtD
Moclobemide—Dermatitis—Cisplatin—germ cell cancer	0.000623	0.00258	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—germ cell cancer	0.00062	0.00256	CcSEcCtD
Moclobemide—CYP2D6—brain—germ cell cancer	0.000619	0.00382	CbGeAlD
Moclobemide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000617	0.00255	CcSEcCtD
Moclobemide—Malaise—Methotrexate—germ cell cancer	0.0006	0.00248	CcSEcCtD
Moclobemide—Dizziness—Etoposide—germ cell cancer	0.000599	0.00248	CcSEcCtD
Moclobemide—Nausea—Cisplatin—germ cell cancer	0.000588	0.00243	CcSEcCtD
Moclobemide—Vomiting—Etoposide—germ cell cancer	0.000576	0.00238	CcSEcCtD
Moclobemide—Rash—Etoposide—germ cell cancer	0.000571	0.00236	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—germ cell cancer	0.000571	0.00236	CcSEcCtD
Moclobemide—Headache—Etoposide—germ cell cancer	0.000568	0.00235	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—germ cell cancer	0.000566	0.00234	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—germ cell cancer	0.000566	0.00234	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—germ cell cancer	0.000559	0.00231	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—germ cell cancer	0.000547	0.00226	CcSEcCtD
Moclobemide—Nausea—Etoposide—germ cell cancer	0.000538	0.00223	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000525	0.00217	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—germ cell cancer	0.000507	0.0021	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000495	0.00204	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—germ cell cancer	0.000491	0.00203	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—germ cell cancer	0.000487	0.00202	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—germ cell cancer	0.000484	0.002	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—germ cell cancer	0.000483	0.002	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—germ cell cancer	0.000478	0.00198	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—germ cell cancer	0.000472	0.00195	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—germ cell cancer	0.000468	0.00193	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—germ cell cancer	0.000447	0.00185	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000444	0.00184	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—germ cell cancer	0.000431	0.00178	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—germ cell cancer	0.000429	0.00177	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—germ cell cancer	0.000389	0.00161	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—germ cell cancer	0.000384	0.00159	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—germ cell cancer	0.000371	0.00154	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—germ cell cancer	0.000359	0.00148	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—germ cell cancer	0.000345	0.00143	CcSEcCtD
Moclobemide—Rash—Methotrexate—germ cell cancer	0.000342	0.00142	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—germ cell cancer	0.000342	0.00141	CcSEcCtD
Moclobemide—Headache—Methotrexate—germ cell cancer	0.00034	0.00141	CcSEcCtD
Moclobemide—Nausea—Methotrexate—germ cell cancer	0.000322	0.00133	CcSEcCtD
